Sfoglia per Autore
Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study
2023-01-01 Bellini, Stefania; Guarrera, Simonetta; Matullo, Giuseppe; Schalkwijk, Casper; Stehouwer, Coen D; Chaturvedi, Nish; Soedamah-Muthu, Sabita S; Barutta, Federica; Gruden, Gabriella
Novel Insight into the Mechanisms of the Bidirectional Relationship between Diabetes and Periodontitis
2022-01-01 Barutta F.; Bellini S.; Durazzo M.; Gruden G.
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy
2022-01-01 Barutta, F; Bellini, S; Kimura, S; Hase, K; Corbetta, B; Corbelli, A; Fiordaliso, F; Bruno, S; Biancone, L; Barreca, A; Papotti, M G; Hirsh, E; Martini, M; Gambino, R; Durazzo, M; Ohno, H; Gruden, G
Mechanisms of podocyte injury and implications for diabetic nephropathy
2022-01-01 Barutta F.; Bellini S.; Gruden G.
Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study
2022-01-01 Barutta, Federica; Bellini, Stefania; Guarrera, Simonetta; Matullo, Giuseppe; Schalkwijk, Casper; Stehouwer, Coen D; Chaturvedi, Nish; Soedamah-Muthu, Sabita S; Durazzo, Marilena; Gruden, Gabriella
Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease
2021-01-01 Gruden G.; Carucci P.; Barutta F.; Burt D.; Ferro A.; Rolle E.; Pinach S.; Abate M.L.; Campra D.; Durazzo M.
Reduced thiamine availability and hyperglycemia impair thiamine transport in renal glomerular cells through modulation of thiamine transporter 2
2021-01-01 Mazzeo A.; Barutta F.; Bellucci L.; Trento M.; Gruden G.; Porta M.; Beltramo E.
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes
2021-01-01 Barutta, Federica; Kimura, Shunsuke; Hase, Koji; Bellini, Stefania; Corbetta, Beatrice; Corbelli, Alessandro; Fiordaliso, Fabio; Barreca, Antonella; Papotti, Mauro Giulio; Ghiggeri, Gian Marco; Salvidio, Gennaro; Roccatello, Dario; Audrito, Valentina; Deaglio, Silvia; Gambino, Roberto; Bruno, Stefania; Camussi, Giovanni; Martini, Miriam; Hirsch, Emilio; Durazzo, Marilena; Ohno, Hiroshi; Gruden, Gabriella
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
2021-01-01 Barutta F.; Corbetta B.; Bellini S.; Guarrera S.; Matullo G.; Scandella M.; Schalkwijk C.; Stehouwer C.D.; Chaturvedi N.; Soedamah-Muthu S.S.; Durazzo M.; Gruden G.
Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report
2021-01-01 Gruden G.; Beggiato E.; Camerino E.; Capriotti S.; Canepa S.; Scandella M.; Avolio M.; Pittalunga F.; Barutta F.; Durazzo M.
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems
2021-01-01 Wouters K.; Cento A.S.; Gaens K.H.; Teunissen M.; Scheijen J.L.J.M.; Barutta F.; Chiazza F.; Collotta D.; Aragno M.; Gruden G.; Collino M.; Schalkwijk C.G.; Mastrocola R.
Novel biomarkers of diabetic kidney disease: current status and potential clinical application
2021-01-01 Barutta F.; Bellini S.; Canepa S.; Durazzo M.; Gruden G.
Self-management education may improve blood pressure in people with type 2diabetes. A randomized controlled clinical trial.
2020-01-01 Marina Trento, Paolo Fornengo, Cristina Amione, Martina Salassa, Federica Barutta, Gabriella Gruden, Aurora Mazzeo, Stefano Merlo, MarioChiesa,Franco Cavallo, Lorena Charrier, Massimo Porta.
Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update
2020-01-01 Durazzo, Marilena; Lupi, Giulia; Cicerchia, Francesca; Ferro, Arianna; Barutta, Federica; Beccuti, Guglielmo; Gruden, Gabriella; Pellicano, Rinaldo
Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society
2020-01-01 Di Paolo S.; Fiorentino M.; De Nicola L.; Reboldi G.; Gesualdo L.; Barutta F.; Natali A.; Penno G.; Fioretto P.; Pugliese G.
The future of diabetic kidney disease management: what to expect from the experimental studies?
2020-01-01 Barutta F.; Bellini S.; Corbetta B.; Durazzo M.; Gruden G.
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”
2020-01-01 Pugliese G.; Penno G.; Natali A.; Barutta F.; Di Paolo S.; Reboldi G.; Gesualdo L.; De Nicola L.
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”
2019-01-01 Pugliese G.; Penno G.; Natali A.; Barutta F.; Di Paolo S.; Reboldi G.; Gesualdo L.; De Nicola L.
The co-activator-associated arginine methyltransferase 1 (CARM1) gene is overexpressed in type 2 diabetes.
2019-01-01 Massimo Porta, Cristina Amione, Federica Barutta, Paolo Fornengo, Stefano Merlo, Gabriella Gruden, Luigi Albano, Marco Ciccarelli, Paola Ungaro, Marilena Durazzo, Francesco Beguinot, Paola Berchialla, Franco Cavallo, Marina Trento.
SGLT2 inhibition to address the unmet needs in diabetic nephropathy
2019-01-01 Barutta, F; Bernardi, S; Gargiulo, G; Durazzo, M; Gruden, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study | 2023 | Bellini, Stefania; Guarrera, Simonetta; Matullo, Giuseppe; Schalkwijk, Casper; Stehouwer, Coen D; Chaturvedi, Nish; Soedamah-Muthu, Sabita S; Barutta, Federica; Gruden, Gabriella | |
| Novel Insight into the Mechanisms of the Bidirectional Relationship between Diabetes and Periodontitis | 2022 | Barutta F.; Bellini S.; Durazzo M.; Gruden G. | |
| Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy | 2022 | Barutta, F; Bellini, S; Kimura, S; Hase, K; Corbetta, B; Corbelli, A; Fiordaliso, F; Bruno, S; Biancone, L; Barreca, A; Papotti, M G; Hirsh, E; Martini, M; Gambino, R; Durazzo, M; Ohno, H; Gruden, G | |
| Mechanisms of podocyte injury and implications for diabetic nephropathy | 2022 | Barutta F.; Bellini S.; Gruden G. | |
| Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study | 2022 | Barutta, Federica; Bellini, Stefania; Guarrera, Simonetta; Matullo, Giuseppe; Schalkwijk, Casper; Stehouwer, Coen D; Chaturvedi, Nish; Soedamah-Muthu, Sabita S; Durazzo, Marilena; Gruden, Gabriella | |
| Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease | 2021 | Gruden G.; Carucci P.; Barutta F.; Burt D.; Ferro A.; Rolle E.; Pinach S.; Abate M.L.; Campra D.; Durazzo M. | |
| Reduced thiamine availability and hyperglycemia impair thiamine transport in renal glomerular cells through modulation of thiamine transporter 2 | 2021 | Mazzeo A.; Barutta F.; Bellucci L.; Trento M.; Gruden G.; Porta M.; Beltramo E. | |
| Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes | 2021 | Barutta, Federica; Kimura, Shunsuke; Hase, Koji; Bellini, Stefania; Corbetta, Beatrice; Corbelli, Alessandro; Fiordaliso, Fabio; Barreca, Antonella; Papotti, Mauro Giulio; Ghiggeri, Gian Marco; Salvidio, Gennaro; Roccatello, Dario; Audrito, Valentina; Deaglio, Silvia; Gambino, Roberto; Bruno, Stefania; Camussi, Giovanni; Martini, Miriam; Hirsch, Emilio; Durazzo, Marilena; Ohno, Hiroshi; Gruden, Gabriella | |
| MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS | 2021 | Barutta F.; Corbetta B.; Bellini S.; Guarrera S.; Matullo G.; Scandella M.; Schalkwijk C.; Stehouwer C.D.; Chaturvedi N.; Soedamah-Muthu S.S.; Durazzo M.; Gruden G. | |
| Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report | 2021 | Gruden G.; Beggiato E.; Camerino E.; Capriotti S.; Canepa S.; Scandella M.; Avolio M.; Pittalunga F.; Barutta F.; Durazzo M. | |
| Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems | 2021 | Wouters K.; Cento A.S.; Gaens K.H.; Teunissen M.; Scheijen J.L.J.M.; Barutta F.; Chiazza F.; Collotta D.; Aragno M.; Gruden G.; Collino M.; Schalkwijk C.G.; Mastrocola R. | |
| Novel biomarkers of diabetic kidney disease: current status and potential clinical application | 2021 | Barutta F.; Bellini S.; Canepa S.; Durazzo M.; Gruden G. | |
| Self-management education may improve blood pressure in people with type 2diabetes. A randomized controlled clinical trial. | 2020 | Marina Trento, Paolo Fornengo, Cristina Amione, Martina Salassa, Federica Barutta, Gabriella Gruden, Aurora Mazzeo, Stefano Merlo, MarioChiesa,Franco Cavallo, Lorena Charrier, Massimo Porta. | |
| Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update | 2020 | Durazzo, Marilena; Lupi, Giulia; Cicerchia, Francesca; Ferro, Arianna; Barutta, Federica; Beccuti, Guglielmo; Gruden, Gabriella; Pellicano, Rinaldo | |
| Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society | 2020 | Di Paolo S.; Fiorentino M.; De Nicola L.; Reboldi G.; Gesualdo L.; Barutta F.; Natali A.; Penno G.; Fioretto P.; Pugliese G. | |
| The future of diabetic kidney disease management: what to expect from the experimental studies? | 2020 | Barutta F.; Bellini S.; Corbetta B.; Durazzo M.; Gruden G. | |
| Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” | 2020 | Pugliese G.; Penno G.; Natali A.; Barutta F.; Di Paolo S.; Reboldi G.; Gesualdo L.; De Nicola L. | |
| Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” | 2019 | Pugliese G.; Penno G.; Natali A.; Barutta F.; Di Paolo S.; Reboldi G.; Gesualdo L.; De Nicola L. | |
| The co-activator-associated arginine methyltransferase 1 (CARM1) gene is overexpressed in type 2 diabetes. | 2019 | Massimo Porta, Cristina Amione, Federica Barutta, Paolo Fornengo, Stefano Merlo, Gabriella Gruden, Luigi Albano, Marco Ciccarelli, Paola Ungaro, Marilena Durazzo, Francesco Beguinot, Paola Berchialla, Franco Cavallo, Marina Trento. | |
| SGLT2 inhibition to address the unmet needs in diabetic nephropathy | 2019 | Barutta, F; Bernardi, S; Gargiulo, G; Durazzo, M; Gruden, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile